Vision at Johnson & Johnson has appointed Paul Lisenby as Global Head of Research & Development, Vision, effective August 4, 2025.
Paul will be responsible for shaping the global R&D strategy and driving innovation across the Vision portfolio. With a strong focus on accelerating transformative solutions, Paul will leverage his impressive track record of cross-functional leadership in new product development to drive the strong technology pipeline and increase the Company’s cadence of launching breakthrough innovations in eye health.
“We are thrilled to welcome Paul back to lead Research and Development for Vision at Johnson & Johnson,” shared Peter Menziuso, Company Group Chairman, Vision, J&J. “His wealth of experience in leading scientific discovery all the way through to introducing novel solutions will be critical as we build on our legacy of firsts and bring forward the next wave of material and optical innovation.”
Extensive Experience in Medical Technology Leadership
Paul brings extensive global expertise, having served as a product development leader for several large medical technology companies. He returns to Vision at Johnson & Johnson to lead R&D, where he worked over 25 years ago. His experience in leading global innovation teams will help bring transformative solutions to patients and eye care professionals around the world.
“Vision health is central to global well-being, and I am passionate to help accelerate scientific breakthroughs with unwavering urgency to improve eye health for the millions of patients we serve around the world,” said Paul Lisenby, Global Head of R&D, Vision, J&J. “I am excited to further fuel the strong momentum this team has created. Together we will push the boundaries of technology and deliver innovations that make a meaningful difference in people’s lives.”
